Literature DB >> 18798222

Breast cancer special types: why bother?

J S Reis-Filho1, S R Lakhani.   

Abstract

Breast cancer is a heterogeneous disease, encompassing multiple entities associated with distinct biological features and clinical behaviours. Microarray-based expression profiling analysis has been used to unravel the molecular underpinning of several characteristics of breast cancer, including its proclivity to disseminate to distant sites and the molecular basis of histological grade. Furthermore, a breast cancer molecular classification based on transcriptional analysis has been proposed. However, microarray studies have primarily analysed invasive ductal carcinomas of no special type. Histological special types of breast cancer, which account for up to 25% of all invasive breast cancers, have not been systematically studied. Despite the limited interest, in recent years it has become apparent that the histopathological characteristics of these cancers may be underpinned by distinct arrays of genetic changes, providing direct evidence for genotypic-phenotypic correlations between morphological patterns and molecular changes in breast cancer (eg t(12;15) in secretory carcinoma of the breast). Here we review the molecular characteristics of special types of breast cancer, with special emphasis on their microarray-based expression profiles and their impact on our understanding of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798222     DOI: 10.1002/path.2419

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

2.  Basal-like breast cancer displays distinct patterns of promoter methylation.

Authors:  Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar
Journal:  Cancer Biol Ther       Date:  2010-06-18       Impact factor: 4.742

3.  Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.

Authors:  Deepthi Rao; Bruce F Kimler; Warren B Nothnick; Marilyn K Davis; Fang Fan; Ossama Tawfik
Journal:  Hum Pathol       Date:  2015-03-10       Impact factor: 3.466

4.  Epidemiology of triple negative breast cancers.

Authors:  Gretchen L Gierach; Aileen Burke; William F Anderson
Journal:  Breast Dis       Date:  2010

Review 5.  Breast cancer proteomics: a review for clinicians.

Authors:  E R C G N Galvão; L M S Martins; J O Ibiapina; H M Andrade; S J H Monte
Journal:  J Cancer Res Clin Oncol       Date:  2011-04-05       Impact factor: 4.553

Review 6.  Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.

Authors:  F Giugliano; J Uliano; V A A Zia; D Trapani; A Marra; G Viale; E Ferraro; A Esposito; C Criscitiello; P D'amico; G Curigliano
Journal:  Breast Cancer Res Treat       Date:  2021-05-27       Impact factor: 4.872

Review 7.  Histological and molecular types of breast cancer: is there a unifying taxonomy?

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675

Review 8.  Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.

Authors:  Vida Pourteimoor; Samira Mohammadi-Yeganeh; Mahdi Paryan
Journal:  Tumour Biol       Date:  2016-09-20

Review 9.  Do 'basal-like' breast cancers really exist?

Authors:  Barry Gusterson
Journal:  Nat Rev Cancer       Date:  2008-12-29       Impact factor: 60.716

10.  Next-generation sequencing.

Authors:  Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.